ES2433593T3 - Formulaciones farmacéuticas que comprenden un derivado de piridina sustituido - Google Patents
Formulaciones farmacéuticas que comprenden un derivado de piridina sustituido Download PDFInfo
- Publication number
- ES2433593T3 ES2433593T3 ES10182072T ES10182072T ES2433593T3 ES 2433593 T3 ES2433593 T3 ES 2433593T3 ES 10182072 T ES10182072 T ES 10182072T ES 10182072 T ES10182072 T ES 10182072T ES 2433593 T3 ES2433593 T3 ES 2433593T3
- Authority
- ES
- Spain
- Prior art keywords
- pyridin
- morpholin
- dimethyl
- acetamide
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65842805P | 2005-03-03 | 2005-03-03 | |
| DK200500321 | 2005-03-03 | ||
| US658428P | 2005-03-03 | ||
| DKPA200500321 | 2005-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2433593T3 true ES2433593T3 (es) | 2013-12-11 |
Family
ID=37908541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10182072T Expired - Lifetime ES2433593T3 (es) | 2005-03-03 | 2006-03-02 | Formulaciones farmacéuticas que comprenden un derivado de piridina sustituido |
Country Status (13)
| Country | Link |
|---|---|
| KR (2) | KR20130088905A (pt) |
| CN (3) | CN101133053A (pt) |
| AR (1) | AR052931A1 (pt) |
| BR (1) | BRPI0608122A2 (pt) |
| DK (1) | DK2298766T3 (pt) |
| EA (1) | EA016244B1 (pt) |
| ES (1) | ES2433593T3 (pt) |
| IL (1) | IL185113A (pt) |
| NZ (1) | NZ556613A (pt) |
| PT (1) | PT2298766E (pt) |
| SI (1) | SI2298766T1 (pt) |
| UA (1) | UA92340C2 (pt) |
| ZA (1) | ZA200705987B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114409593B (zh) * | 2022-01-20 | 2024-02-23 | 上海泾维化工科技有限公司 | 一种2-氨基-5-甲基吡啶的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE380176T1 (de) * | 1999-08-04 | 2007-12-15 | Icagen Inc | Benzanilide als öffner des kaliumkanals |
| MXPA03000032A (es) * | 2000-06-29 | 2003-08-19 | Neurosearch As | Uso de derivados de oxindol 3-sustituidos como moduladores de los canales de potasio kcnq. |
| CZ20032233A3 (cs) * | 2001-02-20 | 2004-12-15 | Bristol-Myers Squibb Company | Derivát 2,4-disubstituovaného pyrimidin-5-karboxamidu jako modulátor draslíkového kanálku KCNQ |
| WO2004082677A1 (en) * | 2003-03-21 | 2004-09-30 | H. Lundbeck A/S | Substituted p-diaminobenzene derivatives |
| TWI349666B (en) * | 2004-03-12 | 2011-10-01 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivatives |
-
2006
- 2006-02-03 UA UAA200710648A patent/UA92340C2/ru unknown
- 2006-03-02 KR KR1020137019572A patent/KR20130088905A/ko not_active Ceased
- 2006-03-02 DK DK10182072.8T patent/DK2298766T3/da active
- 2006-03-02 AR ARP060100790A patent/AR052931A1/es unknown
- 2006-03-02 SI SI200631682T patent/SI2298766T1/sl unknown
- 2006-03-02 ZA ZA200705987A patent/ZA200705987B/xx unknown
- 2006-03-02 BR BRPI0608122-3A patent/BRPI0608122A2/pt not_active IP Right Cessation
- 2006-03-02 PT PT101820728T patent/PT2298766E/pt unknown
- 2006-03-02 CN CNA2006800068313A patent/CN101133053A/zh active Pending
- 2006-03-02 EA EA200701877A patent/EA016244B1/ru not_active IP Right Cessation
- 2006-03-02 KR KR1020077019782A patent/KR20070108884A/ko not_active Ceased
- 2006-03-02 ES ES10182072T patent/ES2433593T3/es not_active Expired - Lifetime
- 2006-03-02 CN CN2011103097414A patent/CN102516165A/zh active Pending
- 2006-03-02 NZ NZ556613A patent/NZ556613A/en not_active IP Right Cessation
- 2006-03-02 CN CN201110168073.8A patent/CN102276523B/zh not_active Expired - Fee Related
-
2007
- 2007-08-07 IL IL185113A patent/IL185113A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1164868A1 (en) | 2012-09-28 |
| EA016244B1 (ru) | 2012-03-30 |
| ZA200705987B (en) | 2009-05-27 |
| EA200701877A1 (ru) | 2008-02-28 |
| KR20130088905A (ko) | 2013-08-08 |
| PT2298766E (pt) | 2013-11-07 |
| CN102516165A (zh) | 2012-06-27 |
| CN102276523A (zh) | 2011-12-14 |
| CN101133053A (zh) | 2008-02-27 |
| CN102276523B (zh) | 2014-12-10 |
| IL185113A (en) | 2013-10-31 |
| AR052931A1 (es) | 2007-04-11 |
| DK2298766T3 (da) | 2013-11-11 |
| KR20070108884A (ko) | 2007-11-13 |
| SI2298766T1 (sl) | 2014-05-30 |
| IL185113A0 (en) | 2007-12-03 |
| BRPI0608122A2 (pt) | 2010-11-09 |
| NZ556613A (en) | 2010-11-26 |
| UA92340C2 (en) | 2010-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2298766B1 (en) | Pharmaceutical formulations comrpising a substituted pyridine derivative | |
| ES2334076T3 (es) | Derivados de morfolina y tiomorfolina sustituidos. | |
| EA008907B1 (ru) | Производные индола | |
| ES2433593T3 (es) | Formulaciones farmacéuticas que comprenden un derivado de piridina sustituido | |
| CA2621854A1 (en) | Pyrimidine derivatives and their use as kcnq potassium channels openers | |
| HK1117842A (en) | Substituted pyridine derivatives | |
| HK1164868B (en) | Substituted pyridine derivatives | |
| HK1172339A (en) | Substituted pyridine derivatives | |
| HK1172618B (en) | Substituted morpholine and thiomorpholine derivatives |